Tag: Price Negotiations

Aetna Will Apply Pharmacy Rebates to Prescription Drugs in 2019 | HealthPayer Intelligence

Aetna Will Apply Pharmacy Rebates to Prescription Drugs in 2019 | HealthPayer Intelligence

“We have always believed that consumers should benefit from discounts and rebates that we negotiate with drug manufacturers,” said Mark T. Bertolini, Aetna chairman and CEO. “Going forward, we hope this additional transparency will encourage these companies to rationalize their pricing and end the practice of annual double-digit price increases.” Aetna believes that improving prescription […]

Drug middlemen clash with FDA over blame for high prices | Washington Examiner

Drug middlemen clash with FDA over blame for high prices | Washington Examiner

“Contrary to today’s remarks, pharmacy benefit managers have long been strong supporters of bipartisan legislation that would prevent brand drug manufacturer abuses of risk evaluation and mitigation strategies that block generic competition,” according to a statement from the PBM group Pharmaceutical Care Management Association. The Campaign for Sustainable Rx Pricing, an advocacy group that has […]

Why Some Schools Pay More Than Others When Buying From Apple | WIRED

Why Some Schools Pay More Than Others When Buying From Apple | WIRED

WHEN ADMINISTRATORS IN Ohio’s Mentor Public Schools were buying MacBooks during the 2015-16 school year, the local Best Buy was offering a lower price than Apple, even after the company’s standard discount for school districts. Superintendent Matt Miller pushed for a better deal, but Apple said it would not budge from its price list. The […]

Making sure the price is right | Houston Chronicle

Making sure the price is right | Houston Chronicle

Martin Fraenkel is president of S& P Global Platts, the leading independent provider of benchmark prices for crude oil, refined products, natural gas and a variety of other commodities. Platts tracks transactions at ports and other locations and publishes price benchmarks used in energy and commodities trading around the world. Platts’ more recent efforts include […]

Publishing drug prices, selling straight to hospitals are in plans for nonprofit drug venture with STL ties | stltoday.com

Publishing drug prices, selling straight to hospitals are in plans for nonprofit drug venture with STL ties | stltoday.com

A hospital-backed nonprofit generic drug manufacturer has radical plans for the drug industry as it prepares to launch operations later this year. Leaders of the drugmaker said they planned to publish drug prices in an effort to force more transparency in an industry that is known for being opaque. Utah-based Intermountain Healthcare is leading the […]

Insulin pricing transparency bill passes out of committee | State of Reform

Insulin pricing transparency bill passes out of committee | State of Reform

Rep. Dylan Roberts’ bill to add transparency around drug pricing for Coloradans with diabetes passed the House Health, Insurance & Environment Committee today. About 200,000 Coloradans take insulin, a life-or-death drug for all Type 1 diabetes patients and for many Type 2 patients. HB18-1009, a part of the House Democrats’ consumer protection agenda, is sponsored […]

Flashpoint: Hoosiers should not support changes to the 340B Drug Pricing Program | tribstar.com

Flashpoint: Hoosiers should not support changes to the 340B Drug Pricing Program | tribstar.com

Two things are true now, more than ever before: health care is expensive and prescription drug prices are sky-high. Indiana residents — especially those in rural areas, who have to travel long distances for a doctor — are struggling to seek treatment and afford medication. This is why the little-known 340B Drug Pricing Program has […]

Soaring drug prices? Here’s how to control them | WTVA

Soaring drug prices? Here’s how to control them | WTVA

Prices and profit margins Not surprisingly, prices and profit margins for prescription drugs in the United States dwarf those in foreign markets. It is obvious that economics represent a key incentive for the constant innovation and first access to life-saving drugs that Americans enjoy. Indeed, that is the conundrum: The same policies that are associated […]

“Rigged” Pricing, Contracting And Rebate “Schemes,” And Drug Pricing “Shell Games:” FDA Commissioner Scott Gottlieb Lets Loose On The U.S. Biosimilar Market While Offering Peek At New Policies | Mondaq

“Rigged” Pricing, Contracting And Rebate “Schemes,” And Drug Pricing “Shell Games:” FDA Commissioner Scott Gottlieb Lets Loose On The U.S. Biosimilar Market While Offering Peek At New Policies | Mondaq

In a few short days, the United States will mark the eight-year anniversary of the Biologics Price Competition and Innovation Act (“BPCIA”). Signed into law on March 23, 2010, the BPCIA creates a regulatory pathway for the approval of biosimilar drugs in the United States and a mechanism, albeit voluntary, for resolving patent right disputes […]

Azar demands price transparency, but how will he achieve it? | Modern Healthcare

Azar demands price transparency, but how will he achieve it? | Modern Healthcare

HHS Secretary Alex Azar has thrown down a passionate—and personal—challenge to healthcare providers and drugmakers, demanding they tell patients what a service or product will cost before they receive it. “Especially if we want to move to a system where we put patients more in charge of their own healthcare dollars, providers and insurers have […]